tiprankstipranks
Trending News
More News >
Petros Pharmaceuticals (PTPI)
OTHER OTC:PTPI
US Market
Advertisement

Petros Pharmaceuticals (PTPI) Stock Statistics & Valuation Metrics

Compare
201 Followers

Total Valuation

Petros Pharmaceuticals has a market cap or net worth of $856.90K. The enterprise value is -$8.04M.
Market Cap$856.90K
Enterprise Value-$8.04M

Share Statistics

Petros Pharmaceuticals has 31,160,086 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding31,160,086
Owned by Insiders
Owned by Institutions0.13%

Financial Efficiency

Petros Pharmaceuticals’s return on equity (ROE) is 1.92 and return on invested capital (ROIC) is 21749.66%.
Return on Equity (ROE)1.92
Return on Assets (ROA)-1.35
Return on Invested Capital (ROIC)21749.66%
Return on Capital Employed (ROCE)2.39
Revenue Per Employee284.00K
Profits Per Employee-795.49K
Employee Count18
Asset Turnover0.48
Inventory Turnover0.90

Valuation Ratios

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.
PE Ratio
PS Ratio0.00
PB Ratio>-0.01
Price to Fair Value-10.59
Price to FCF-0.29
Price to Operating Cash Flow-0.01
PEG Ratio<0.01

Income Statement

In the last 12 months, Petros Pharmaceuticals had revenue of 5.11M and earned -14.32M in profits. Earnings per share was -0.02.
Revenue5.11M
Gross Profit3.90M
Operating Income-17.68M
Pretax Income-14.32M
Net Income-14.32M
EBITDA-10.81M
Earnings Per Share (EPS)-0.02

Cash Flow

In the last 12 months, operating cash flow was -2.96M and capital expenditures -24.59K, giving a free cash flow of -2.99M billion.
Operating Cash Flow-2.96M
Free Cash Flow-2.99M
Free Cash Flow per Share-0.10

Dividends & Yields

Petros Pharmaceuticals pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta1.92
52-Week Price Change-99.71%
50-Day Moving Average0.06
200-Day Moving Average4.42
Relative Strength Index (RSI)29.37
Average Volume (3m)562.43K

Important Dates

Petros Pharmaceuticals upcoming earnings date is ―, ―.
Last Earnings Date
Next Earnings Date
Ex-Dividend Date

Financial Position

Petros Pharmaceuticals as a current ratio of 0.40, with Debt / Equity ratio of 0.00%
Current Ratio0.40
Quick Ratio0.33
Debt to Market Cap0.09
Net Debt to EBITDA-0.34
Interest Coverage Ratio-31.52

Taxes

In the past 12 months, Petros Pharmaceuticals has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00

Enterprise Valuation

Petros Pharmaceuticals EV to EBITDA ratio is -7.65, with an EV/FCF ratio of -31.49.
EV to Sales16.18
EV to EBITDA-7.65
EV to Free Cash Flow-31.49
EV to Operating Cash Flow-31.78

Balance Sheet

Petros Pharmaceuticals has $8.93M in cash and marketable securities with $0.00 in debt, giving a net cash position of -$8.93M billion.
Cash & Marketable Securities$8.93M
Total Debt$0.00
Net Cash-$8.93M
Net Cash Per Share-$0.29
Tangible Book Value Per Share-$1.33

Margins

Gross margin is 76.34%, with operating margin of -345.84%, and net profit margin of -280.10%.
Gross Margin76.34%
Operating Margin-345.84%
Pretax Margin-280.10%
Net Profit Margin-280.10%
EBITDA Margin-211.54%
EBIT Margin-269.13%

Analyst Forecast

The average price target for Petros Pharmaceuticals is ―, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target
Price Target Upside
Analyst ConsensusModerate Buy
Analyst Count0
Revenue Growth Forecast
EPS Growth Forecast

Scores

Smart ScoreN/A
AI Score
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis